Artykuły w czasopismach na temat „Antibody-toxin conjugates”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Antibody-toxin conjugates”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Esteva, Francisco J., Kathy D. Miller i Beverly A. Teicher. "What Can We Learn about Antibody-Drug Conjugates from the T-DM1 Experience?" American Society of Clinical Oncology Educational Book, nr 35 (maj 2015): e117-e125. http://dx.doi.org/10.14694/edbook_am.2015.35.e117.
Pełny tekst źródłaAhmad, Ateeq, i Kevin Law. "Strategies for designing antibody-toxin conjugates". Trends in Biotechnology 6, nr 10 (październik 1988): 246–51. http://dx.doi.org/10.1016/0167-7799(88)90056-x.
Pełny tekst źródłaGovindan, Serengulam V., i David M. Goldenberg. "New Antibody Conjugates in Cancer Therapy". Scientific World JOURNAL 10 (2010): 2070–89. http://dx.doi.org/10.1100/tsw.2010.191.
Pełny tekst źródłaLiang, X. P., M. E. Lamm i J. G. Nedrud. "Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus." Journal of Immunology 141, nr 5 (1.09.1988): 1495–501. http://dx.doi.org/10.4049/jimmunol.141.5.1495.
Pełny tekst źródłaPanjideh, Hossein, Nicole Niesler, Alexander Weng i Hendrik Fuchs. "Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861". Toxins 14, nr 7 (13.07.2022): 478. http://dx.doi.org/10.3390/toxins14070478.
Pełny tekst źródłaFaria, Morse, Marlking Peay, Brandon Lam, Eric Ma, Moucun Yuan, Michael Waldron, William Mylott, Meina Liang i Anton Rosenbaum. "Multiplex LC-MS/MS Assays for Clinical Bioanalysis of MEDI4276, an Antibody-Drug Conjugate of Tubulysin Analogue Attached via Cleavable Linker to a Biparatopic Humanized Antibody against HER-2". Antibodies 8, nr 1 (11.01.2019): 11. http://dx.doi.org/10.3390/antib8010011.
Pełny tekst źródłaYu, Rui, Junjie Xu, Tao Hu i Wei Chen. "The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity". Mediators of Inflammation 2020 (4.07.2020): 1–11. http://dx.doi.org/10.1155/2020/9596129.
Pełny tekst źródłaMarsh, J. W., i D. M. Neville. "A flexible peptide spacer increases the efficacy of holoricin anti-T cell immunotoxins." Journal of Immunology 140, nr 10 (15.05.1988): 3674–78. http://dx.doi.org/10.4049/jimmunol.140.10.3674.
Pełny tekst źródłaGovindan, Serengulam V., Gary L. Griffiths, Hans J. Hansen, Ivan D. Horak i David M. Goldenberg. "Cancer Therapy with Radiolabeled and Drug/Toxin-conjugated Antibodies". Technology in Cancer Research & Treatment 4, nr 4 (sierpień 2005): 375–91. http://dx.doi.org/10.1177/153303460500400406.
Pełny tekst źródłaLefeber, Dirk J., Barry Benaissa-Trouw, Johannes F. G. Vliegenthart, Johannis P. Kamerling, Wouter T. M. Jansen, Kees Kraaijeveld i Harm Snippe. "Th1-Directing Adjuvants Increase the Immunogenicity of Oligosaccharide-Protein Conjugate Vaccines Related to Streptococcus pneumoniae Type 3". Infection and Immunity 71, nr 12 (grudzień 2003): 6915–20. http://dx.doi.org/10.1128/iai.71.12.6915-6920.2003.
Pełny tekst źródłaMesserschmidt, Katrin, i Katja Heilmann. "Toxin–antigen conjugates as selection tools for antibody producing cells". Journal of Immunological Methods 387, nr 1-2 (styczeń 2013): 167–72. http://dx.doi.org/10.1016/j.jim.2012.10.010.
Pełny tekst źródłaARNDT, R., i H. J. THIESEN. "Elimination of Trinitrophenol-Specific Antibody Response by Antigen-Toxin Conjugates". Scandinavian Journal of Immunology 22, nr 5 (listopad 1985): 489–94. http://dx.doi.org/10.1111/j.1365-3083.1985.tb01907.x.
Pełny tekst źródłaOu, Li, Krishana Gulla, Andrea Biju, Daniel W. Biner, Tatsiana Bylund, Anita Changela, Steven J. Chen i in. "Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1". Vaccines 10, nr 11 (12.11.2022): 1916. http://dx.doi.org/10.3390/vaccines10111916.
Pełny tekst źródłaJohansson, Eva-Liz, Carola Rask, Margareta Fredriksson, Kristina Eriksson, Cecil Czerkinsky i Jan Holmgren. "Antibodies and Antibody-Secreting Cells in the Female Genital Tract after Vaginal or Intranasal Immunization with Cholera Toxin B Subunit or Conjugates". Infection and Immunity 66, nr 2 (1.02.1998): 514–20. http://dx.doi.org/10.1128/iai.66.2.514-520.1998.
Pełny tekst źródłaChen, Zhaochun, Rachel Schneerson, Julie A. Lovchik, Zhongdong Dai, Joanna Kubler-Kielb, Liane Agulto, Stephen H. Leppla i Robert H. Purcell. "Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax". Clinical and Vaccine Immunology 22, nr 8 (3.06.2015): 902–8. http://dx.doi.org/10.1128/cvi.00137-15.
Pełny tekst źródłaTrad, Ahmad, Hinrich P. Hansen, Mohammad Shomali, Matthias Peipp, Katja Klausz, Nina Hedemann, Kosuke Yamamoto i in. "ADAM17-overexpressing breast cancer cells selectively targeted by antibody–toxin conjugates". Cancer Immunology, Immunotherapy 62, nr 3 (1.09.2012): 411–21. http://dx.doi.org/10.1007/s00262-012-1346-x.
Pełny tekst źródłaBergquist, C., T. Lagergård, M. Lindblad i J. Holmgren. "Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates." Infection and immunity 63, nr 5 (1995): 2021–25. http://dx.doi.org/10.1128/iai.63.5.2021-2025.1995.
Pełny tekst źródłaSellrie, F., i B. Micheel. "Selection of recombinant antibody-producing E. coli cells by means of toxin conjugates". Biochemical Engineering Journal 38, nr 3 (marzec 2008): 309–13. http://dx.doi.org/10.1016/j.bej.2007.07.017.
Pełny tekst źródłaTedder, T. F., V. S. Goldmacher, J. M. Lambert i S. F. Schlossman. "Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system." Journal of Immunology 137, nr 4 (15.08.1986): 1387–91. http://dx.doi.org/10.4049/jimmunol.137.4.1387.
Pełny tekst źródłaPrice, Gregory A., Michael W. Russell i Cynthia Nau Cornelissen. "Intranasal Administration of Recombinant Neisseria gonorrhoeae Transferrin Binding Proteins A and B Conjugated to the Cholera Toxin B Subunit Induces Systemic and Vaginal Antibodies in Mice". Infection and Immunity 73, nr 7 (lipiec 2005): 3945–53. http://dx.doi.org/10.1128/iai.73.7.3945-3953.2005.
Pełny tekst źródłaSpeirs, Joan I., i Mumtaz Akhtar. "Detection of Escherichia coli cytotoxins by enzyme-linked immunosorbent assays". Canadian Journal of Microbiology 37, nr 8 (1.08.1991): 650–53. http://dx.doi.org/10.1139/m91-110.
Pełny tekst źródłaSeong, Seung-Yong, Nam-Hyuk Cho, Ick Chan Kwon i Seo Young Jeong. "Protective Immunity of Microsphere-Based Mucosal Vaccines against Lethal Intranasal Challenge withStreptococcus pneumoniae". Infection and Immunity 67, nr 7 (1.07.1999): 3587–92. http://dx.doi.org/10.1128/iai.67.7.3587-3592.1999.
Pełny tekst źródłaPolito, Letizia, Giulia Calafato, Massimo Bortolotti, Cecilia Chiarelli Olivari, Stefania Maiello i Andrea Bolognesi. "Antibody Conjugates for Sarcoma Therapy: How Far along Are We?" Biomedicines 9, nr 8 (8.08.2021): 978. http://dx.doi.org/10.3390/biomedicines9080978.
Pełny tekst źródłaKarsten, Lennard, Nils Janson, Vadim Le Joncour, Sarfaraz Alam, Benjamin Müller, Jayendrakishore Tanjore Ramanathan, Pirjo Laakkonen, Norbert Sewald i Kristian M. Müller. "Bivalent EGFR-Targeting DARPin-MMAE Conjugates". International Journal of Molecular Sciences 23, nr 5 (23.02.2022): 2468. http://dx.doi.org/10.3390/ijms23052468.
Pełny tekst źródłaPeeters, C. C., A. M. Tenbergen-Meekes, C. J. Heijnen, J. T. Poolman, B. J. Zegers i G. T. Rijkers. "In vitro induction of a Haemophilus influenzae type b polysaccharide-specific antibody response in human peripheral blood lymphocytes of individuals recently vaccinated with an oligosaccharide-protein conjugate." Journal of Immunology 147, nr 12 (15.12.1991): 4192–99. http://dx.doi.org/10.4049/jimmunol.147.12.4192.
Pełny tekst źródłaLu, Ying-Jie, Sophie Forte, Claudette M. Thompson, Porter W. Anderson i Richard Malley. "Protection against Pneumococcal Colonization and Fatal Pneumonia by a Trivalent Conjugate of a Fusion Protein with the Cell Wall Polysaccharide". Infection and Immunity 77, nr 5 (2.03.2009): 2076–83. http://dx.doi.org/10.1128/iai.01554-08.
Pełny tekst źródłaSenter, Peter D., Marilyn J. Tansey, John M. Lambert i Walter A. Blattler. "NOVEL PHOTOCLEAVABLE PROTEIN CROSSLINKING REAGENTS AND THEIR USE IN THE PREPARATION OF ANTIBODY-TOXIN CONJUGATES". Photochemistry and Photobiology 42, nr 3 (wrzesień 1985): 231–37. http://dx.doi.org/10.1111/j.1751-1097.1985.tb08936.x.
Pełny tekst źródłaLiu, Yongheng, Wei Lian, Xi Zhao, Wei Qi, Jian Xu, Liang Xiao, Yan Qing, Tongtong Xue i Jingyi Wang. "A phase I study of safety and pharmacokinetics of A166, a novel selective inhibitor of human epidermal growth factor receptor-2 in Chinese patients with advanced solid tumors." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): e13007-e13007. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13007.
Pełny tekst źródłaDardevet, Lucie, Feten Najlaoui, Sonia Aroui, Mayeul Collot, Céline Tisseyre, Michael W. Pennington, Jean-Maurice Mallet i Michel De Waard. "A Conjugate between Lqh-8/6, a Natural Peptide Analogue of Chlorotoxin, and Doxorubicin Efficiently Induces Glioma Cell Death". Biomedicines 10, nr 10 (17.10.2022): 2605. http://dx.doi.org/10.3390/biomedicines10102605.
Pełny tekst źródłaPalanca-Wessels, Maria Corinna, i Oliver W. Press. "Advances in the treatment of hematologic malignancies using immunoconjugates". Blood 123, nr 15 (10.04.2014): 2293–301. http://dx.doi.org/10.1182/blood-2013-10-492223.
Pełny tekst źródłaHammond, Philip W., Omid Vafa, Jonathan Jacinto, Jost Vielmetter, Sher Karki, Sean Yoder, Greg Lazar i in. "A Humanized Anti-CD30 Monoclonal Antibody, XmAb™2513, with Enhanced In Vitro Potency Against CD30-Positive Lymphomas Mediated by High Affinity Fc-Receptor Binding." Blood 106, nr 11 (16.11.2005): 1470. http://dx.doi.org/10.1182/blood.v106.11.1470.1470.
Pełny tekst źródłaPorath, Kendra A., Ann Mladek, Rachael A. Vaubel, Michael S. Regan, Sonia Jain, Danielle Burgenske, Katrina Bakken i in. "Abstract 334: Convection enhanced delivery of EGFR-targeting antibody drug conjugates ABBV-321 and Depatux-M". Cancer Research 82, nr 12_Supplement (15.06.2022): 334. http://dx.doi.org/10.1158/1538-7445.am2022-334.
Pełny tekst źródłaAmbrosino, D. M., D. Bolon, H. Collard, R. Van Etten, M. V. Kanchana i R. W. Finberg. "Effect of Haemophilus influenzae polysaccharide outer membrane protein complex conjugate vaccine on macrophages." Journal of Immunology 149, nr 12 (15.12.1992): 3978–83. http://dx.doi.org/10.4049/jimmunol.149.12.3978.
Pełny tekst źródłaDelprino, Laura, Maria Giacomotti, Franco Dosio, Paola Brusa, Maurizio Ceruti, Giorgio Grosa i Luigi Cattel. "Toxin-Targeted Design for Anticancer Therapy. II: Preparation and Biological Comparison of Different Chemically Linked Gelonin-Antibody Conjugates". Journal of Pharmaceutical Sciences 82, nr 7 (lipiec 1993): 699–704. http://dx.doi.org/10.1002/jps.2600820706.
Pełny tekst źródłaHamamichi, Shusei, Takeshi Fukuhara i Nobutaka Hattori. "Immunotoxin Screening System: A Rapid and Direct Approach to Obtain Functional Antibodies with Internalization Capacities". Toxins 12, nr 10 (15.10.2020): 658. http://dx.doi.org/10.3390/toxins12100658.
Pełny tekst źródłaRiedl, Thilo, Egon van Boxtel, Martijn Bosch, Paul W. H. I. Parren i Arnout F. Gerritsen. "High-Throughput Screening for Internalizing Antibodies by Homogeneous Fluorescence Imaging of a pH-Activated Probe". Journal of Biomolecular Screening 21, nr 1 (30.10.2015): 12–23. http://dx.doi.org/10.1177/1087057115613270.
Pełny tekst źródłaPasswell, Justen H., Efrat Harlev, Shai Ashkenazi, Chiayung Chu, Dan Miron, Reut Ramon, Naheed Farzan i in. "Safety and Immunogenicity of ImprovedShigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel". Infection and Immunity 69, nr 3 (1.03.2001): 1351–57. http://dx.doi.org/10.1128/iai.69.3.1351-1357.2001.
Pełny tekst źródłaPestka, James J. "Enhanced Surveillance of Foodborne Mycotoxins by Immunochemical Assay". Journal of AOAC INTERNATIONAL 71, nr 6 (1.11.1988): 1075–81. http://dx.doi.org/10.1093/jaoac/71.6.1075.
Pełny tekst źródłaNiculescu-Duvaz, I., i C. J. Springer. "Antibody-Directed Enzyme Prodrug Therapy (ADEPT): A Targeting Strategy in Cancer Chemotherapy". Current Medicinal Chemistry 2, nr 3 (październik 1995): 687–706. http://dx.doi.org/10.2174/092986730203220223143057.
Pełny tekst źródłaLaske, Douglas W., Orhan Ilercil, Aytac Akbasak, Richard J. Youle i Edward H. Oldfield. "Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice". Journal of Neurosurgery 80, nr 3 (marzec 1994): 520–26. http://dx.doi.org/10.3171/jns.1994.80.3.0520.
Pełny tekst źródłaShi, Xiarong, Leiliane P. Sousa, Elizabeth M. Mandel-Bausch, Francisco Tome, Andrey V. Reshetnyak, Yaron Hadari, Joseph Schlessinger i Irit Lax. "Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition". Proceedings of the National Academy of Sciences 113, nr 33 (1.08.2016): E4784—E4793. http://dx.doi.org/10.1073/pnas.1610179113.
Pełny tekst źródłaManiecki, Maciej Bogdan, Henrik Hasle, Knud Bendix i Holger Jon Møller. "Hepatotoxicity in Patients Treated with Gemtuzumab Ozogamicin - Specific Targeting of Hepatocytes?" Blood 114, nr 22 (20.11.2009): 4150. http://dx.doi.org/10.1182/blood.v114.22.4150.4150.
Pełny tekst źródłaValent, Peter, Irina Sadovnik, Gregor Eisenwort, Karin Bauer, Harald Herrmann, Karoline V. Gleixner, Axel Schulenburg, Werner Rabitsch, Wolfgang R. Sperr i Dominik Wolf. "Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML". International Journal of Molecular Sciences 20, nr 17 (29.08.2019): 4233. http://dx.doi.org/10.3390/ijms20174233.
Pełny tekst źródłaBendell, Johanna C., Judy Sing-Zan Wang, Babar Bashir, Debra L. Richardson, Gavin Bennett, Carly Campbell, Meliessa G. Hennessy i in. "BT5528-100 phase I/II study of the safety, pharmacokinetics, and preliminary clinical activity of BT5528 in patients with advanced malignancies associated with EphA2 expression." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): TPS3655. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.tps3655.
Pełny tekst źródłaCabello-Alemán, Lucía. "Future directions in cancer immunotherapy with monoclonal antibodies". Research Results in Pharmacology 8, nr 4 (15.12.2022): 101–7. http://dx.doi.org/10.3897/rrpharmacology.8.85918.
Pełny tekst źródłaMahheidari, Naimeh, Jamal Rashidiani, Hamid Kooshki i Khadijeh Eskandari. "An Effort to Making a Colorimitric Nano-Biosensor for Vibrio cholera Detection". Current Nanoscience 16, nr 5 (5.10.2020): 793–804. http://dx.doi.org/10.2174/1573413716666191230154316.
Pełny tekst źródłaAkter, Sultana, Teemu Kustila, Janne Leivo, Gangatharan Muralitharan, Markus Vehniäinen i Urpo Lamminmäki. "Noncompetitive Chromogenic Lateral-Flow Immunoassay for Simultaneous Detection of Microcystins and Nodularin". Biosensors 9, nr 2 (18.06.2019): 79. http://dx.doi.org/10.3390/bios9020079.
Pełny tekst źródłaWrobel, Charles J., Donald C. Wright, Robert L. Dedrick i Richard J. Youle. "Diphtheria toxin effects on brain-tumor xenografts". Journal of Neurosurgery 72, nr 6 (czerwiec 1990): 946–50. http://dx.doi.org/10.3171/jns.1990.72.6.0946.
Pełny tekst źródłaBudde, Lihua Elizabeth, Armen Mardiros, Wen-Chung Chang, Xiuli Wang, Carolina Berger, Christine Brown, Stanley R. Riddell, Oliver W. Press i Stephen J. Forman. "Truncated Cell-Surface CD19 As a Conditional Suicide Switch For Adoptive T Cell Immunotherapy". Blood 122, nr 21 (15.11.2013): 1660. http://dx.doi.org/10.1182/blood.v122.21.1660.1660.
Pełny tekst źródłaEriksson, Kristina, Margareta Fredriksson, Inger Nordström i Jan Holmgren. "Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development". Infection and Immunity 71, nr 4 (kwiecień 2003): 1740–47. http://dx.doi.org/10.1128/iai.71.4.1740-1747.2003.
Pełny tekst źródła